Tenon Medical, Inc. Cost of Revenue
Tenon Medical, Inc. (TNON) reported Cost of Revenue of $465.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-13
- Tenon Medical, Inc. cost of revenue for the quarter ending 2026-06-30 was $465.00K, a 45.77% increase year-over-year.
- Tenon Medical, Inc. cost of revenue for the quarter ending 2026-03-31 was $434.00K, a 7.69% increase year-over-year.
- Tenon Medical, Inc. cost of revenue for the quarter ending 2025-12-31 was $464.00K, a 11.27% increase year-over-year.
- Tenon Medical, Inc. cost of revenue for the quarter ending 2025-09-30 was $400.00K, a 14.71% decline year-over-year.
- Tenon Medical, Inc. cost of revenue for fiscal 2025 was $1.59M, a 1.28% increase from fiscal 2024.
- Tenon Medical, Inc. cost of revenue for fiscal 2024 was $1.57M, a 7.17% decline from fiscal 2023.
- Tenon Medical, Inc. cost of revenue for fiscal 2023 was $1.69M, a 26.65% increase from fiscal 2022.
- Tenon Medical, Inc. cost of revenue for fiscal 2022 was $1.33M, a 2321.82% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $465.00K 10-Q · filed 2026-08-13 | $899.00K 10-Q · filed 2026-08-13 | $1.36M derived: sum of 3 quarters · filed 2026-08-13 | $1.76M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $434.00K 10-Q · filed 2026-05-15 | $898.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.30M derived: sum of 3 quarters · filed 2026-05-15 | $1.62M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $464.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $864.00K derived: sum of 2 quarters · filed 2026-03-27 | $1.18M derived: sum of 3 quarters · filed 2026-08-13 | $1.59M 10-K · filed 2026-03-27 |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-13 | $719.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.12M 10-Q · filed 2025-11-13 | $1.54M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $319.00K 10-Q · filed 2026-08-13 | $722.00K 10-Q · filed 2026-08-13 | $1.14M derived: sum of 3 quarters · filed 2026-08-13 | $1.61M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $403.00K 10-Q · filed 2026-05-15 | $820.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.29M derived: sum of 3 quarters · filed 2026-05-15 | $1.72M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $886.00K derived: sum of 2 quarters · filed 2026-03-27 | $1.32M derived: sum of 3 quarters · filed 2026-03-27 | $1.57M 10-K · filed 2026-03-27 |
| 2024-09-30 | $469.00K 10-Q · filed 2025-11-13 | $900.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.15M 10-Q · filed 2025-11-13 | $1.40M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $431.00K 10-Q · filed 2025-08-13 | $680.00K 10-Q · filed 2025-08-13 | $929.00K derived: sum of 3 quarters · filed 2025-08-13 | $1.34M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $249.00K 10-Q · filed 2025-05-13 | $498.00K derived: sum of 2 quarters · filed 2025-05-13 | $907.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.46M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $658.00K derived: sum of 2 quarters · filed 2025-03-26 | $1.21M derived: sum of 3 quarters · filed 2025-03-26 | $1.69M 10-K · filed 2025-03-26 |
| 2023-09-30 | $409.00K 10-Q · filed 2024-11-14 | $958.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.44M 10-Q · filed 2024-11-14 | $1.92M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $549.00K 10-Q · filed 2024-08-13 | $1.03M 10-Q · filed 2024-08-13 | $1.51M derived: sum of 3 quarters · filed 2024-08-13 | $1.81M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $480.00K 10-Q · filed 2024-05-15 | $964.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.27M derived: sum of 3 quarters · filed 2024-05-15 | $1.54M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $484.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $786.00K derived: sum of 2 quarters · filed 2024-03-29 | $1.06M derived: sum of 3 quarters · filed 2024-03-29 | $1.33M 10-K · filed 2024-03-29 |
| 2022-09-30 | $302.00K 10-Q · filed 2023-11-14 | $573.00K derived: sum of 2 quarters · filed 2023-11-14 | $848.00K 10-Q · filed 2023-11-14 | $865.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $271.00K 10-Q · filed 2023-08-11 | $546.00K 10-Q · filed 2023-08-11 | $563.00K derived: sum of 3 quarters · filed 2023-08-11 | $581.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $275.00K 10-Q · filed 2023-05-09 | $292.00K derived: sum of 2 quarters · filed 2023-05-09 | $310.00K derived: sum of 3 quarters · filed 2023-05-09 | $319.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $35.00K derived: sum of 2 quarters · filed 2023-03-10 | $44.00K derived: sum of 3 quarters · filed 2023-03-10 | $55.00K 10-K · filed 2023-03-10 |
| 2021-09-30 | $18.00K 10-Q · filed 2022-11-10 | $27.00K derived: sum of 2 quarters · filed 2022-11-10 | $38.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $9.00K 10-Q · filed 2022-08-12 | $20.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $11.00K 10-Q · filed 2022-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |